143 related articles for article (PubMed ID: 8291217)
1. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Nilsson E; Sjödahl R; Nordenskjöld B
Virchows Arch A Pathol Anat Histopathol; 1993; 423(6):443-8. PubMed ID: 8291217
[TBL] [Abstract][Full Text] [Related]
2. c-erbB-2 oncoprotein in relation to DNA ploidy and prognosis in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Stål O; Zhang H; Nordenskjöld B
APMIS; 1995 Apr; 103(4):309-15. PubMed ID: 7612263
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Zhang H; Stål O; Wingren S; Hatschek T; Nordenskjöld B
Lancet; 1992 Dec; 340(8832):1369-73. PubMed ID: 1360088
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas.
Bosari S; Viale G; Bossi P; Maggioni M; Coggi G; Murray JJ; Lee AK
J Natl Cancer Inst; 1994 May; 86(9):681-7. PubMed ID: 8158699
[TBL] [Abstract][Full Text] [Related]
5. ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.
Sun XF; Wingren S; Carstensen JM; Stål O; Hatschek T; Boeryd B; Nordenskjöld B; Zhang H
Eur J Cancer; 1991; 27(12):1646-9. PubMed ID: 1782077
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas.
Sun XF; Carstensen JM; Zhang H; Arbman G; Nordenskjöld B
Eur J Cancer; 1996 Oct; 32A(11):1963-7. PubMed ID: 8943682
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ras is an independent prognostic factor in colorectal adenocarcinoma.
Sun XF; Ekberg H; Zhang H; Carstensen JM; Nordenskjöld B
APMIS; 1998 Jun; 106(6):657-64. PubMed ID: 9725799
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
9. p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival.
Lanza G; Maestri I; Dubini A; Gafa R; Santini A; Ferretti S; Cavazzini L
Am J Clin Pathol; 1996 May; 105(5):604-12. PubMed ID: 8623770
[TBL] [Abstract][Full Text] [Related]
10. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-erbB-2 and p53 in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Nordenskjöld B
Anal Cell Pathol; 1995 Apr; 8(3):203-11. PubMed ID: 7547494
[TBL] [Abstract][Full Text] [Related]
12. Increased p53 protein content of colorectal tumours correlates with poor survival.
Remvikos Y; Tominaga O; Hammel P; Laurent-Puig P; Salmon RJ; Dutrillaux B; Thomas G
Br J Cancer; 1992 Oct; 66(4):758-64. PubMed ID: 1419618
[TBL] [Abstract][Full Text] [Related]
13. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma: univariate and multivariate analysis.
Tonouchi H; Matsumoto K; Kinoshita T; Itoh H; Suzuki H
Dig Surg; 1998; 15(6):687-92. PubMed ID: 9845638
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non-metastasized colorectal carcinomas (stages IB and II).
Baretton GB; Vogt M; Müller C; Diebold J; Schneiderbanger K; Schmidt M; Löhrs U
Scand J Gastroenterol; 1996 May; 31(5):481-9. PubMed ID: 8734346
[TBL] [Abstract][Full Text] [Related]
19. Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):54-61. PubMed ID: 9454661
[TBL] [Abstract][Full Text] [Related]
20. p53 mutations in L3-loop zinc-binding domain, DNA-ploidy, and S phase fraction are independent prognostic indicators in colorectal cancer: a prospective study with a five-year follow-up.
Russo A; Migliavacca M; Zanna I; Valerio MR; Latteri MA; Grassi N; Pantuso G; Salerno S; Dardanoni G; Albanese I; La Farina M; Tomasino RM; Gebbia N; Bazan V
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1322-31. PubMed ID: 12433709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
